AI MARKET SCANNING

Reviva Pharmaceuticals Holdi

📅 Next Catalyst: Nov 12, 2026 (🌙 Close) 🏛️ OTC MARKETS 📁 Health Technology 🏭 Pharmaceuticals Major
AVG HISTORICAL GAP -1.53%
MAX GAP RECORD -8.01%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $RVPH
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Nov 12, 2026 Earnings Release 2026-11-12 (UNDETERMINED) 🔮 UPCOMING 🔒
Aug 12, 2026 Earnings Release 2026-08-12 (AFTER CLOSE)
+0.00%
May 13, 2026 Earnings Release 2026-05-13 (AFTER CLOSE)
+1.73%
Nov 13, 2025 Earnings Release 2025-11-13 (AFTER CLOSE)
-3.90%
Aug 14, 2025 Earnings Release 2025-08-14 (AFTER CLOSE)
+5.11%
May 15, 2025 Earnings Release 2025-05-15 (AFTER CLOSE)
-1.07%
Nov 14, 2024 Earnings Release 2024-11-14 (AFTER CLOSE)
-0.83%
Aug 14, 2024 Earnings Release 2024-08-14 (BEFORE OPEN)
+0.00%

VOLATILITY & GAP BIAS

AVG GAP MOVE 2.9%
Bullish Gaps (2)
Bearish Gaps (5)
Neutral / Flat (3)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $RVPH

EXECUTIONS0 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
Radar monitoring: awaiting next setup.
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

Reviva Pharmaceuticals Holdings, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapeutics for the central nervous system, respiratory, and metabolic diseases. It uses chemical genomics driven technology platform and proprietary chemistry to develop new medicines. It focuses on the RP5063 (Brilaroxazine) and RP1208 pipelines….

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗